{
    "Trade/Device Name(s)": [
        "LZI 6-Acetylmorphine Enzyme Immunoassay",
        "LZI 6-Acetylmorphine Drugs of Abuse (DAU) Calibrators",
        "LZI 6-Acetylmorphine Drugs of Abuse (DAU) Controls",
        "6-Acetylmorphine Enzyme Immunoassay",
        "6-Acetylmorphine Calibrators and Controls"
    ],
    "Submitter Information": "Lin-Zhi International, Inc.",
    "510(k) Number": "K101195",
    "Predicate Device Reference 510(k) Number(s)": [
        "K001178"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "DJG",
        "DLJ",
        "LAS"
    ],
    "Summary Letter Date": "July 6, 2010",
    "Summary Letter Received Date": "April 29, 2010",
    "Submission Date": "April 28, 2010",
    "Regulation Number(s)": [
        "21 CFR 862.3650",
        "21 CFR 862.3200",
        "21 CFR 862.3280"
    ],
    "Regulation Name(s)": [
        "Opiate test system"
    ],
    "Analyte Class(es)": [
        "toxicology"
    ],
    "Analyte(s)": [
        "6-Acetylmorphine"
    ],
    "Specimen Type(s)": [
        "Urine"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [
        "Automated clinical chemistry analyzers",
        "Hitachi 717 Analyzer"
    ],
    "Method(s)/Technology(ies)": [
        "Homogeneous enzyme immunoassay",
        "Enzyme immunoassay (EIA)"
    ],
    "Methodologies": [
        "Competition immunoassay"
    ],
    "Submission Type(s)": [
        "Assay",
        "Calibrator",
        "Control"
    ],
    "Document Summary": "FDA 510(k) summary for LZI 6-Acetylmorphine Enzyme Immunoassay and associated calibrators and controls for qualitative and semi-quantitative detection of 6-Acetylmorphine in urine",
    "Indications for Use Summary": "Intended for the qualitative and semi-quantitative determination of 6-Acetylmorphine in human urine at a cutoff value of 10 ng/mL on automated clinical chemistry analyzers; calibrators and controls are for use in assay calibration and monitoring.",
    "fda_folder": "Toxicology"
}